Microbial Signature in Adipose Tissue of Crohn’s Disease Patients
暂无分享,去创建一个
F. Tinahones | J. Vendrell | E. Espin | L. Sánchez-Alcoholado | C. Serena | M. Millan | C. Núñez-Roa | S. Fernández-Veledo | E. Maymo-Masip | M. Terrón-Puig | M. M. Rodríguez | B. Espina | Maribel Queipo-Ortuño | M. Martí | M. Menacho | A. Caro | D. Monfort-Ferré | M. Bautista | E. Espín
[1] Patrice D Cani,et al. Microbial signatures in metabolic tissues: a novel paradigm for obesity and diabetes? , 2020, Nature metabolism.
[2] M. Surette,et al. Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity , 2020, Nature Metabolism.
[3] J. Vadivelu,et al. Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia , 2020, PloS one.
[4] D. Charnock-Jones,et al. Human placenta has no microbiome but can harbour potential pathogens , 2019, Nature.
[5] Zhenhua Zhu,et al. Characteristics of mucosa-associated gut microbiota during treatment in Crohn’s disease , 2019, World journal of gastroenterology.
[6] M. Silverberg,et al. 257 – Higher Abundance of Bile Acid-Metabolizing Microbiota is Associated with Type of Disease, Biopsy Location and Mucosal Inflammation in Inflammatory Bowel Disease Patients , 2019, Gastroenterology.
[7] Dara Walsh,et al. AB060. 207. Digital reconstruction of human mesentery development , 2019, Mesentery and Peritoneum.
[8] H. Yao,et al. Fusobacterium and Colorectal Cancer , 2018, Front. Oncol..
[9] F. Tinahones,et al. Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study , 2018, Diabetes Care.
[10] F. Shanahan,et al. Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence , 2018, Journal of Crohn's & colitis.
[11] I. Moreno-Indias,et al. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus , 2017, Front. Microbiol..
[12] N. Borruel,et al. Crohn's Disease Disturbs the Immune Properties of Human Adipose-Derived Stem Cells Related to Inflammasome Activation , 2017, Stem cell reports.
[13] N. Hu,et al. Molecular Characterization of the Human Stomach Microbiota in Gastric Cancer Patients , 2017, Front. Cell. Infect. Microbiol..
[14] F. Crea,et al. Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome. , 2017, International journal of cardiology.
[15] Weiming Zhu,et al. The role of the mesentery in Crohn's disease. , 2017, The lancet. Gastroenterology & hepatology.
[16] Harry Sokol,et al. A microbial signature for Crohn's disease , 2017, Gut.
[17] D. O'Leary,et al. The mesentery: structure, function, and role in disease. , 2016, The lancet. Gastroenterology & hepatology.
[18] J. Vendrell,et al. Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells , 2016, Stem cells.
[19] Krishna R. Kalari,et al. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease , 2016, Scientific Reports.
[20] C. Consolandi,et al. Adipose tissue microbiota in humans: an open issue , 2016, International Journal of Obesity.
[21] Sandra Santos. Doença de Crohn: fator de risco para o carcinoma colorretal , 2016 .
[22] Chittaranjan S. Yajnik,et al. Molecular Characterization and Meta-Analysis of Gut Microbial Communities Illustrate Enrichment of Prevotella and Megasphaera in Indian Subjects , 2016, Front. Microbiol..
[23] M. Leclerc,et al. Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? , 2016, Front. Microbiol..
[24] S. Salminen,et al. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid , 2016, Scientific Reports.
[25] R. Simó,et al. Obesity Determines the Immunophenotypic Profile and Functional Characteristics of Human Mesenchymal Stem Cells From Adipose Tissue , 2016, Stem cells translational medicine.
[26] F. Servant,et al. The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline , 2015, PloS one.
[27] Luzia Valentini,et al. Visceral Adipose Tissue in Patients with Crohn's Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome , 2015, Inflammatory bowel diseases.
[28] K. Aagaard,et al. The preterm placental microbiome varies in association with excess maternal gestational weight gain. , 2015, American journal of obstetrics and gynecology.
[29] Bernard M. Corfe,et al. Dysbiosis of the gut microbiota in disease , 2015, Microbial ecology in health and disease.
[30] F. Magro,et al. Metabolic Inflammation in Inflammatory Bowel Disease: Crosstalk Between Adipose Tissue and Bowel , 2015, Inflammatory bowel diseases.
[31] E. Allen-Vercoe,et al. Fusobacterium and Enterobacteriaceae: important players for CRC? , 2014, Immunology letters.
[32] J. Petrosino,et al. The Placenta Harbors a Unique Microbiome , 2014, Science Translational Medicine.
[33] C. Invitti,et al. Differences in Visceral Fat and Fat Bacterial Colonization between Ulcerative Colitis and Crohn’s Disease. An In Vivo and In Vitro Study , 2013, PloS one.
[34] R. Burcelin,et al. Metagenome and metabolism: the tissue microbiota hypothesis , 2013, Diabetes, obesity & metabolism.
[35] C. Manichanh,et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.
[36] R. Juza,et al. Volumetric Fat Ratio and Not Body Mass Index Is Predictive of Ileocolectomy Outcomes in Crohn's Disease Patients , 2013, Digestive Surgery.
[37] G. Rogler,et al. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease , 2013, Gut.
[38] Karsten Zengler,et al. The microbiome extends to subepidermal compartments of normal skin , 2012, Nature Communications.
[39] H. Gaskins,et al. Microbial pathways in colonic sulfur metabolism and links with health and disease , 2012, Front. Physio..
[40] Francisco Guarner,et al. The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.
[41] Timothy L. Tickle,et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.
[42] S. Mazmanian,et al. Intestinal Microbes in Inflammatory Bowel Diseases , 2012 .
[43] S. Ng,et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota* , 2012, Inflammatory bowel diseases.
[44] B. Birren,et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.
[45] Richard A. Moore,et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.
[46] B. Siegmund. Mesenteric fat in Crohn's disease: the hot spot of inflammation? , 2011, Gut.
[47] Tarah Lynch,et al. Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.
[48] B. Chassaing,et al. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.
[49] H. Tilg,et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.
[50] H. Tajiri,et al. Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. , 2009, Journal of medical microbiology.
[51] N. Borruel,et al. Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa , 2009, Inflammatory bowel diseases.
[52] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[53] H. Freeman. Colorectal cancer risk in Crohn's disease. , 2008, World journal of gastroenterology.
[54] B. Finlay,et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.
[55] U. Gophna,et al. Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.
[56] Philippe Marteau,et al. Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.
[57] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[58] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[59] J. Hampe,et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.
[60] T. Ohkusa,et al. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis , 2003, Gut.
[61] T. Ohkusa,et al. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species‐specific antibody , 2002, Journal of gastroenterology and hepatology.
[62] D. Jewell,et al. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. , 1983, Gut.
[63] D. Jagelman,et al. Loop lleostomy in the Management of Crohn's Colitis in the Debilitated Patient , 1980, Annals of surgery.
[64] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.
[65] D. McIlrath. Diverting ileostomy or colostomy in the management of Crohn's disease of the colon. , 1971, Archives of surgery.
[66] L. Barbosa,et al. Crohn's disease: risk factor for colorectal cancer , 2017 .
[67] M. Toruner,et al. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). , 2014, Journal of Crohn's & colitis.
[68] J. Colombel,et al. [Bacterial translocation in Crohn disease]. , 1992, Gastroenterologie clinique et biologique.